title: Monitoring free light chains in serum using mass spectrometry.
abstract: BACKGROUND
  Serum immunoglobulin free light chains (FLC) are secreted into circulation by plasma cells as a by-product of immunoglobulin production. In a healthy individual the population of FLC is polyclonal as no single cell is secreting more FLC than the total immunoglobulin secreting cell population. In a person with a plasma cell dyscrasia, such as multiple myeloma (MM) or light chain amyloidosis (AL), a clonal population of plasma cells secretes a monoclonal light chain at a concentration above the normal polyclonal background.
  
  
  METHODS
  We recently showed that monoclonal immunoglobulin rapid accurate mass measurement (miRAMM) can be used to identify and quantify a monoclonal light chain (LC) in serum and urine above the polyclonal background. This was accomplished by reducing immunoglobulin disulfide bonds releasing the LC to be analyzed by microLC-ESI-Q-TOF mass spectrometry. Here we demonstrate that the methodology can also be applied to the detection and quantification of FLC by analyzing a non-reduced sample.
  
  
  RESULTS
  Proof of concept experiments were performed using purified FLC spiked into normal serum to assess linearity and precision. In addition, a cohort of 27 patients with AL was analyzed and miRAMM was able to detect a monoclonal FLC in 23 of the 27 patients that had abnormal FLC values by immunonephelometry.
  
  
  CONCLUSIONS
  The high resolution and high mass measurement accuracy provided by the mass spectrometry based methodology eliminates the need for κ/λ ratios as the method can quantitatively monitor the abundance of the κ and λ polyclonal background at the same time it measures the monoclonal FLC.
authors: David R
authors: DR
authors: Barnidge
authors: Angela
authors: A
authors: Dispenzieri
authors: Giampaolo
authors: G
authors: Merlini
authors: Jerry A
authors: JA
authors: Katzmann
authors: David L
authors: DL
authors: Murray
mesh_terms: D000068879:Adalimumab / Q000097:blood; D000686:Amyloidosis / Q000097:blood / Q000276:immunology; D006801:Humans; D007143:Immunoglobulin Heavy Chains / Q000097:blood; D007145:Immunoglobulin kappa-Chains / Q000097:blood* / Q000652:urine; D007146:Immunoglobulin lambda-Chains / Q000097:blood* / Q000652:urine; D021241:Spectrometry, Mass, Electrospray Ionization
chemical_list: D007143:Immunoglobulin Heavy Chains; D007145:Immunoglobulin kappa-Chains; D007146:Immunoglobulin lambda-Chains; D000068879:Adalimumab